Fangzhou Inc.
HKSE: 6086.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Consumer Cyclical
- Industry
- Drug Manufacturers - General
- CEO
- Haijiao Wang
- Employees
- 488
- Headquarters
- Guangzhou, China
- IPO year
- 2024
- Market cap
- HK$1.7B
- Website
- https://Jianke.com
Loading 6086…
Loading profile data…Frequently asked questions about 6086
What does Fangzhou Inc. (6086.HK) do?
Fangzhou Inc. provides online chronic disease management services in China. The company provides services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It offers H2H services, including online medical consultation se...
Where does 6086.HK trade?
Fangzhou Inc. (6086.HK) trades on the Hong Kong Stock Exchange.
What sector is 6086.HK in?
Fangzhou Inc. (6086.HK) operates in the Consumer Cyclical sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Fangzhou Inc.?
Haijiao Wang is the chief executive officer of Fangzhou Inc. (6086.HK).
Where is Fangzhou Inc. headquartered?
Fangzhou Inc. is headquartered in China.
Does 6086.HK pay a dividend?
Fangzhou Inc. (6086.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6086.HK go public?
Fangzhou Inc. (6086.HK) completed its initial public offering in 2024.